Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2.1M | 3 | 99.9% |
| Travel and Lodging | $2,206 | 8 | 0.1% |
| Food and Beverage | $425.00 | 9 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Grifols, S.A. | $2.1M | 1 | $0 (2021) |
| Incyte Corporation | $13,701 | 19 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $2.1M | 1 | Grifols, S.A. ($2.1M) |
| 2018 | $7,556 | 8 | Incyte Corporation ($7,556) |
| 2017 | $6,145 | 11 | Incyte Corporation ($6,145) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/16/2021 | Grifols, S.A. | — | Consulting Fee | Cash or cash equivalent | $2,103,458.22 | General |
| 05/04/2018 | Incyte Corporation | — | Consulting Fee | Cash or cash equivalent | $6,150.00 | General |
| 05/04/2018 | Incyte Corporation | — | Food and Beverage | Cash or cash equivalent | $50.00 | General |
| 05/04/2018 | Incyte Corporation | — | Food and Beverage | Cash or cash equivalent | $50.00 | General |
| 05/04/2018 | Incyte Corporation | — | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| 05/04/2018 | Incyte Corporation | — | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| 05/03/2018 | Incyte Corporation | — | Travel and Lodging | Cash or cash equivalent | $711.54 | General |
| 05/03/2018 | Incyte Corporation | — | Travel and Lodging | Cash or cash equivalent | $318.06 | General |
| 05/03/2018 | Incyte Corporation | — | Travel and Lodging | Cash or cash equivalent | $226.86 | General |
| 10/27/2017 | Incyte Corporation | JAKAFI (Drug) | Consulting Fee | Cash or cash equivalent | $4,920.00 | General |
| Category: Hematology/Oncology | ||||||
| 10/27/2017 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $50.00 | General |
| Category: Hematology/Oncology | ||||||
| 10/27/2017 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $50.00 | General |
| Category: Hematology/Oncology | ||||||
| 10/27/2017 | Incyte Corporation | JAKAFI (Drug) | Travel and Lodging | Cash or cash equivalent | $50.00 | General |
| Category: Hematology/Oncology | ||||||
| 10/27/2017 | Incyte Corporation | JAKAFI (Drug) | Travel and Lodging | Cash or cash equivalent | $46.04 | General |
| Category: Hematology/Oncology | ||||||
| 10/27/2017 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Hematology/Oncology | ||||||
| 10/27/2017 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Hematology/Oncology | ||||||
| 10/26/2017 | Incyte Corporation | JAKAFI (Drug) | Travel and Lodging | Cash or cash equivalent | $408.40 | General |
| Category: Hematology/Oncology | ||||||
| 10/26/2017 | Incyte Corporation | JAKAFI (Drug) | Travel and Lodging | Cash or cash equivalent | $243.60 | General |
| Category: Hematology/Oncology | ||||||
| 10/26/2017 | Incyte Corporation | JAKAFI (Drug) | Travel and Lodging | Cash or cash equivalent | $201.48 | General |
| Category: Hematology/Oncology | ||||||
| 10/26/2017 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Hematology/Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 39 | 61 | $22,497 | $7,030 |
| 2022 | 1 | 12 | 13 | $5,906 | $1,738 |
| 2021 | 3 | 74 | 229 | $85,074 | $22,585 |
| 2020 | 3 | 63 | 165 | $95,438 | $16,130 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 26 | 44 | $15,025 | $5,585 | 37.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 13 | 17 | $7,472 | $1,445 | 19.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 12 | 13 | $5,906 | $1,738 | 29.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 14 | 124 | $45,632 | $11,673 | 25.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 29 | 53 | $21,018 | $6,501 | 30.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 31 | 52 | $18,424 | $4,411 | 23.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 36 | 97 | $68,968 | $10,170 | 14.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 14 | 48 | $17,664 | $4,664 | 26.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 13 | 20 | $8,806 | $1,296 | 14.7% |
About Everett Meyer, MD PHD
Everett Meyer, MD PHD is a Hematology & Oncology healthcare provider based in Stanford, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2008. The National Provider Identifier (NPI) number assigned to this provider is 1508013517.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Everett Meyer, MD PHD has received a total of $2.1M in payments from pharmaceutical and medical device companies, with $2.1M received in 2021. These payments were reported across 20 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($2.1M).
As a Medicare-enrolled provider, Meyer has provided services to 188 Medicare beneficiaries, totaling 468 services with total Medicare billing of $47,483. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology
- Location Stanford, CA
- Active Since 08/20/2008
- Last Updated 04/15/2024
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1508013517
Products in Payments
- JAKAFI (Drug) $6,145
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Stanford
Sandra Horning, M.d, M.D
Hematology & Oncology — Payments: $1.9M
George Fisher, Md, MD
Hematology & Oncology — Payments: $202,617
Joel Neal, M.d., Ph.d, M.D., PH.D
Hematology & Oncology — Payments: $169,917
Lipika Goyal, Md, MD
Hematology & Oncology — Payments: $157,376
David Miklos, M.d., Ph. D, M.D., PH. D
Hematology & Oncology — Payments: $131,666
Bruno Medeiros, Md, MD
Hematology & Oncology — Payments: $101,545